Novo Nordisk's CFO discusses Wegovy sales and Cagrisema timings in a recent video interview. As a leading manufacturer of diabetes treatments, Novo Nordisk continues to invest in innovative products like Wegovy, a weight management medication. The company's financial performance is closely watched by investors due to its significant market presence.

Source: https://www.bloomberg.com/news/videos/2024-11-06/novo-nordisk-cfo-on-wegovy-sales-cagrisema-timings